A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.

A combination of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) has been a standard therapy for histologically aggressive non-Hodgkin's lymphomas for over 20 years, but several newer regimens, referred to as second or third generation, have been reported to give improved res...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Linch, D. C., Vaughan Hudson, B., Hancock, B. W., Hoskin, P. J., Cunningham, D. C., Newland, A. C., Milligan, D. W., Stevenson, P. A., Wood, J. K., MacLennan, K. A., Anderson, L., Gregory, W. M., Vaughan Hudson, G.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1996
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2074593/
https://ncbi.nlm.nih.gov/pubmed/8688344
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados